Page 272 - Eshre Final Programme 2015

P-661 Preimplantation genetic screening in combination with cumulus cells gene expression profile: use in assessment of embryo potential
E. Lopez-Bayghen1, A. Ocampo2, I. Maldonado3, F. Camargo2
1Ingenes and Cinvestav-IPN, Toxicology, Mexico DF, Mexico 2Instituto Ingenes, Investigación, Mexico DF, Mexico 3Instituto Ingenes, FIV, Mexico DF, Mexico
P-662 Decrease in complex aneuploidies during embryo development from day-3 to blastocyst stage
M. Riboldi1, M.E. Poo2, B. Coprerski3, M. Santos3, C.L. Bandeira3, N. Al-Asmar Piñar4, L. Rodrigo5, C. Simon6, C. Rubio5
1IGENOMIX BRASIL Laboratório de Medicina Genética Ltda., Genetic, São Paulo SP, Brazil 2IGENOMIX, Embriologist, Valencia, Spain
3IGENOMIX BRASIL Laboratório de Medicina Genética Ltda., Biologist, São Paulo SP, Brazil 4IVIGEN, Genetic, Miami, U.S.A.
5IGENOMIX, Genetic, Valencia, Spain
6Fundación Instituto Valenciano de Infertilidad (FIVI) Instituto Universitario IVI/INCLIVA Valencia University Department of Obstetrics and Gynecology School of Medicine Stanford University., Doctor, Valencia, Spain
P-663 Clinical, obstetric and neonatal outcomes of Hungarian preimplantation genetic diagnosis for aneuploidy (PGD-A) cycles of the year 2013
A. Vereczkey1, G.Y. Téglás1, E. Margittai1, M. Csenki1, L. Nánássy1
1Versys Clinics, Human Reproduction Institute, Budapest, Hungary
272